Share Name Share Symbol Market Type Share ISIN Share Description
Fevertree Drinks LSE:FEVR London Ordinary Share GB00BRJ9BJ26 ORD 0.25P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -17.00p -1.02% 1,651.00p 1,651.00p 1,654.00p 1,671.00p 1,648.00p 1,665.00p 78,575 12:46:41
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Beverages 102.2 34.3 23.9 69.2 1,902.63

Fevertree (FEVR) Latest News

More Fevertree News
Fevertree Takeover Rumours

Fevertree (FEVR) Share Charts

1 Year Fevertree Chart

1 Year Fevertree Chart

1 Month Fevertree Chart

1 Month Fevertree Chart

Intraday Fevertree Chart

Intraday Fevertree Chart

Fevertree (FEVR) Discussions and Chat

Fevertree Forums and Chat

Date Time Title Posts
21/6/201721:43FEVER TREE with chart602
20/6/201719:53Fevertree Drinks PLC (Fever-Tree)1,011
07/11/201423:50Is Fever Tree fairly Valued?-

Add a New Thread

Fevertree (FEVR) Most Recent Trades

Trade Time Trade Price Trade Size Trade Value Trade Type
11:46:411,651.002343,863.34AT
11:44:271,654.001151,902.10AT
11:43:481,654.0060992.40O
11:38:261,654.00891,472.06O
11:32:191,654.0059975.86O
View all Fevertree trades in real-time

Fevertree (FEVR) Top Chat Posts

DateSubject
22/6/2017
09:20
Fevertree Daily Update: Fevertree Drinks is listed in the Beverages sector of the London Stock Exchange with ticker FEVR. The last closing price for Fevertree was 1,668p.
Fevertree Drinks has a 4 week average price of 1,592p and a 12 week average price of 1,480p.
The 1 year high share price is 1,780p while the 1 year low share price is currently 626p.
There are currently 115,240,896 shares in issue and the average daily traded volume is 510,461 shares. The market capitalisation of Fevertree Drinks is £1,902,627,192.96.
19/6/2017
11:02
discodave4: bambooGuess the ramper bought 11th May, share price - low:1693, High:1734, close:1707.Also guess he bought above £17, hence the constant ramping about £17+.Tbh don't give a monkeys, just can't abide over the top ramping, no need for it, they are stupid to think it will influence the price.DD
11/6/2017
09:42
devalpha: I echo the comments of posters here who are questioning why the consensus forecasts for 2017 show a massive deceleration in sales growth.None of us has a crystal ball, but we all make investment decisions based on our experience, insight and future expectations. My view is that the consensus forecasts are way too low. In the UK you can clearly see momentum continuing to build on the base of the strengthening brand awareness. The big unknown is the non uk current growth picture. This is what will ultimately determine how much further the share price has to go. We all make our own choices. For me, after taking all current info into consideration, including the valuation, I'm going nowhere. Courage required here in my opinion.
10/6/2017
12:13
henchard: Here are some actual numbers for 2016 and forecast numbers for 2017 and 2018 (based on the current share price of 1,714p): ..........2016.....2017.....2018 EPS.......23.86p...27.68p...31.06p Growth....106.2%...16.0%....12.2% P/E.......71.8x....61.9x....55.2x Surely the shares are way too high at these P/Es for the forecast growth. The PEG ratio for 2017 is 3.9. For the PEG to get to the "fair value" benchmark of 1 (let alone a "growth-at-a-reasonable-price" level of below 1) FEVR would have to do EPS of 35.4p in 2017, which is 28% higher than the current consensus and 22% higher than the most bullish analyst, who's forecasting 29p EPS according to the FT. I could see FEVR beating EPS forecasts but not to the extent of 35.4p or higher. The alternative, of course, is that the share price would have to fall significantly for the valuation to become attractive.
27/5/2017
19:53
christh: Fever-Tree founder sells £73m worth of shares The next round is on Charles. Fever-Tree founder Charles Rolls has cashed in on the company’s recent success, taking advantage of its 900% share price increase to sell £73m worth of stock in the group. The mixer maker reported today that Mr Rolls had sold around 3.9% of the company’s shares to institutional investors at a price of £16.25 per share – a 6% discount on yesterday’s closing price. The total was 80% more than Mr Rolls had originally intended to sell, due to “significant institutional demand”. It’s not hard to see why people might be interested: shares in Fever-Tree have risen more than 50% this year alone and are currently up 924% since its IPO in late 2014. After the sale, Mr Rolls still owns around 11.2% of the company, and he has agreed not to dispose of any more shares in the next 6 months. https://www.ft.com/content/17771fdb-af77-3cd3-849d-78c417348081
24/5/2017
17:39
terry topper: In this instance I am inclined to believe that there is genuine institutional demand and Rolls is helping to meet this (while at the same time trousering a very large wedge!). In addition he is now non-exec and is a good bit older than Tim Warrillow. Warrillow must also have been asked if he wanted to participate, and declined which is a huge positive. It suggests that trading continues to be very strong in my view. I am also in no doubt that enquiries will have been made by the large multinational consumer groups so he will know that he has a straightforward exit at some point. Hopefully there will be significant demand that will leave new institutions looking to pick up additional shares after the placing to meet their 'unit' sizes. In that case I suspect the scenario that Villarich mentions above re G4M is highly likely and we could see the FEVR price heading towards £19-20.
16/5/2017
08:39
martywidget: May 16, 2017 at 05:00 AIM-listed premium soft drinks company Fevertree Drinks (FEVR) is on course to beat expectations this year but Shore Capital says there need to be significant upgrades to justify the current price. Analyst Phil Carroll retained his ‘hold’ recommendation on the stock, which was trading down 1%, or 18p, at £16.86 at the time of writing. Fevertree issued a trading update which shows it is maintaining momentum. ‘Despite an exceptional 2016, momentum in the first four months of 2017 is strong enough to justify management guiding to an expectation that results for the current year will be comfortably ahead of market expectations,’ said Carroll. ‘Following discussions with the company we expect to increase our revenue and profit before tax expectations by c.5%, noting our forecasts are starting ahead of consensus.’ An increase in forecasts would equate to profit before tax rising from £38.7 million to £40.6 million this year, which Carroll said would ‘imply the shares are trading on a full year 2017 price/earnings ratio of 59.6 times’. ‘Our analysis shows that the valuation requires significant upgrades to justify the current share price. Therefore, we retain our “hold” recommendation,’ he said. Http://citywire.co.uk/money/the-expert-view-888-fevertree-and-astrazeneca/a1016633?ref=citywire-money-latest-news-list#i=6
15/5/2017
19:37
big7ime: I so love these articles Diageo is a massive co, the huge catalogue of a report makes amazing reading. If you compared the two you'd realise there is no comparison, Diageo a world leader mega conglomerate selling hundreds of brands in two hundred countries, it's going to be a slower mover than a newer exciting growth co But it's a quality co. Fevr is a newish co, in comparison an upstart fizzy drinks co with a few soft drinks. Quality product but nothing that can't be replicated but compare it to Diageo you realise the ridiculous over valuation given to it by those joining the party at this late stage throwing their cash at it like it's going to have a twentieth the profits of Diageo valuing it now at a potential many years down the line. So a completely different kind of investment. One a proven blue chip with good dividend, the other a much higher risk investment that even if the business continues to grow yr on yr for many years could be reaching its pinnacle in terms of share price." Wow, sums it up
15/5/2017
08:33
topvest: What a great company this is. Trouble is that the share price is now so high that an AHEAD profit update is already priced in. More downside than upside in the share price if you ask me. If you logically put a cap on how much this brand could ultimately be worth (top-end) it can't be much more than £3-5bn and its already valued at £2bn. Just my view. Obviously I wasn't smart enough to spot this great company 2/3 years ago so well done to those that spotted this early.
12/4/2017
12:03
walbrock82: Fevertree Drink is a great and straightforward business to understand. The shares became an 11 bagger in just 28 months! But analysts forecast for Fevertree going forward doesn’t look fundamentally great with estimates of revenue for 2017 and 2018 at £119m and £136m respectively. Meanwhile, EPS is estimated at 26 pence/share for 2017, and 29 pence/share in 2018. Remember, 2016’s EPS is 23.7 pence/share. Below is a summary of Fevertree: - The company sells premium mixers at 36 pence per 100ml vs. Schweppes’s 22 pence. - It operates in over 50 different markets, especially in two most important locations of Europe and America. - It raised £90m from its IPOs, this money is instrumental in paying off past loans. -The net margin grew to 26%. - Capex spending is £1m per year. But, as sales grow, will it have enough capacity to fulfil larger orders? -Fevertree’s cash balance has ballooned from £3m to £33m making it cash generative. -Management cash in some early success by selling combined shares worth £17m at £6.25 per share. -Last year was a breakout year for Fevertree with revenue up 72%. But analysts could spoil the party if estimates of between 14% and 16% revenue growth for 2017 and 2018 comes true. It would make the shares look overvalue. -The share price more than doubled from a year ago. Found the above information interesting, then click for more analysis and charts: http://bit.ly/fevertree-drinks-share-price-worth-investing-today
06/4/2017
15:29
greek islander: New high of 1553 reached before a pull back. Share price looking stronger than ever. More news inside the next 2-3 months about current trading should further inflate the share price The market needs reassurance that revenue continues to rise and then we shall be looking at £20. wetdream, the Asos pe may look ridiculous but it has been double that and more in the past. It is the clear market leader with a huge loyal following and though I no longer hold it after cashing in at just under £40 more than a couple of years back. It has nearly always had the potential to be a £100 stock. Be interesting to see if FEVR which has more international revenue and therefore potential gets there before it.
Fevertree share price data is direct from the London Stock Exchange
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:40 V: D:20170622 12:04:32